Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic predisposition to lung cancer.

Literature DB >> 2178665

Genetic predisposition to lung cancer.

M R Law¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1990 PMID： 2178665 PMCID： PMC1971391 DOI： 10.1038/bjc.1990.37

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

111 in total

1. The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors: E S Vesell
Journal: Clin Pharmacol Ther Date: 1979-09 Impact factor: 6.875

2. Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22.

Authors: M Eichelbaum; M P Baur; H J Dengler; B O Osikowska-Evers; G Tieves; C Zekorn; C Rittner
Journal: Br J Clin Pharmacol Date: 1987-04 Impact factor: 4.335

3. Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse.

Authors: D W Nebert; F M Goujon; J E Gielen
Journal: Nat New Biol Date: 1972-03-29

4. The incidence of genetic disease in a University hospital population.

Authors: N Day; L B Holmes
Journal: Am J Hum Genet Date: 1973-05 Impact factor: 11.025

5. Genetic and environmental factors affecting ethanol metabolism in man.

Authors: E S Vesell; J G Page; G T Passananti
Journal: Clin Pharmacol Ther Date: 1971 Mar-Apr Impact factor: 6.875

6. Impairement of drug metabolism in tumor-bearing animals.

Authors: R Rosso; M G Donelli; G Franchi; S Garattini
Journal: Eur J Cancer Date: 1971-12 Impact factor: 9.162

7. Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.

Authors: M Danhof; D D Breimer
Journal: Br J Clin Pharmacol Date: 1979-12 Impact factor: 4.335

8. A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin.

Authors: E Steiner; L Iselius; G Alván; J Lindsten; F Sjöqvist
Journal: Clin Pharmacol Ther Date: 1985-10 Impact factor: 6.875

9. Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi.

Authors: C C Harris; H Autrup; R Connor; L A Barrett; E M McDowell; B F Trump
Journal: Science Date: 1976-12-03 Impact factor: 47.728

10. HLA antigens and primary bronchial carcinoma.

Authors: M M Tongio; C Kerschen; G Pauli; N Roeslin; D Grange; S Mayer
Journal: Cancer Date: 1982-06-15 Impact factor: 6.860

7 in total

1. Debrisoquine oxidation phenotype and susceptibility to lung cancer.

Authors: A R Boobis; D S Davies
Journal: Br J Clin Pharmacol Date: 1990-10 Impact factor: 4.335

2. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.

Authors: I Roots; J Brockmöller; N Drakoulis; R Loddenkemper
Journal: Clin Investig Date: 1992 Mar-Apr

3. Oxidative polymorphism of debrisoquine is not related to human colo-rectal cancer.

Authors: J M Ladero; J Benítez; J F González; E Vargas; M Díaz-Rubio
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

4. The second Bagshawe lecture. Matching basic research to the management of cancer: the view from the other side of the fence.

Authors: J A Wyke
Journal: Br J Cancer Date: 1990-09 Impact factor: 7.640